Kang, Yi
Jin, Qian
Zhou, Mengqi
Zheng, Huijuan
Li, Aoshuang
Li, Danwen
Wang, Xuezhe
Zhou, Jingwei
Lv, Jie
Wang, Yaoxian
Funding for this research was provided by:
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
National Natural Science Foundation of China (82174342)
Article History
Received: 26 May 2025
Revised: 24 July 2025
Accepted: 9 September 2025
First Online: 13 January 2026
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations in the manuscript. All animal experimental procedures were in accordance with ARRIVE guidelines. The animal study protocol was approved by the the Ethics Committee of Beijing University of Chinese Medicine (BUCM-2023120104-4282). Clinical study I was sanctioned by the Ethics Committee of Dongzhimen Hospital, Beijing University of Chinese Medicine (2022DZMEC-062-03), and Clinical study Ⅱ was approved by the Ethics Committee of Dongzhimen Hospital, Beijing University of Chinese Medicine (2023DZMEC-481-01) and adhered to the principles outlined in the Declaration of Helsinki.
: All authors read and approved the final manuscript.
: The authors declare no competing interests.
: Not applicable.